SCHEMBL28210876

SCHEMBL28210876

[CH2]c1cccc2[nH]cc(C)c12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 3/20 0.48
ATM Q13315 1/20 0.47
HTR2A P28223 7/20 0.37
KDM4E B2RXH2 1/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
KMT2A Q03164 1/20 0.37
FFAR1 O14842 1/20 0.36
HTR2C P28335 3/20 0.35
HTR2B P41595 3/20 0.35
CYP2A6 P11509 1/20 0.34
DRD1 P21728 2/20 0.33
DRD3 P35462 2/20 0.33
C5AR1 P21730 1/20 0.33
NR4A2 P43354 1/20 0.33
HTR1A P08908 1/20 0.33
HTR1D P28221 1/20 0.33
HTR1B P28222 1/20 0.33
HTR1E P28566 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5924727 0.83 GPR84 (0.58) GPR84ATMHTR2AFFAR1HTR2C
SCHEMBL1224614 0.80 GPR84 (0.64) GPR84ATMHTR2AKDM4EMEN1
SCHEMBL30552280 0.80 GPR84 (0.64) GPR84ATMHTR2AKDM4EMEN1
SCHEMBL18708141 0.77 GPR84 (0.50) GPR84ATMHTR2AKDM4EMEN1
SCHEMBL12120939 0.75 GPR84 (0.58) GPR84ATMHTR2AKDM4EMEN1
SCHEMBL13969931 0.75 GPR84 (0.48) GPR84ATMHTR2AKDM4EMEN1
SCHEMBL3614670 0.75 CYP2A6 (0.55) GPR84ATMHTR2AKDM4EMEN1
SCHEMBL12093634 0.75 GPR84 (0.58) GPR84ATMHTR2AKDM4EMEN1
SCHEMBL31663257 0.75 CYP2A6 (0.55) GPR84ATMHTR2AKDM4EMEN1
SCHEMBL398138 0.75 GPR84 (0.48) GPR84ATMHTR2AKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108137542-A Pyridone diformamide as bromine structural domain inhibitor 葛兰素史克知识产权第二有限公司 2018-06-08 CN disclosed
CN-107873030-A 5‑HT2CReceptor agonists and compositions and methods of use 艾尼纳制药公司 2018-04-03 CN disclosed